Literature DB >> 10477844

Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia.

E Totsuka1, F Dodson, A Urakami, N Moras, T Ishii, M C Lee, J Gutierrez, M Gerardo, E Molmenti, J J Fung.   

Abstract

Donor hypernatremia was reported to cause postoperative graft dysfunction in human orthotopic liver transplantation (OLT). However, the effects of the correction of donor hypernatremia before organ procurement have not been confirmed. The aim of this study is to determine whether donor hypernatremia is associated with early graft dysfunction after OLT and to determine the effect of the correction of donor hypernatremia. One hundred eighty-one consecutive OLTs performed between May 1997 and July 1998 were entered onto this study. The cases were divided into three groups according to the donor serum sodium concentration: group A, serum sodium of 155 mEq/L or less before organ procurement (n = 118); group B, peak sodium greater than 155 mEq/L and final sodium 155 mEq/L or less (n = 36); and group C, final sodium greater than 155 mEq/L (n = 27). Graft survival within 90 days after OLT and early postoperative graft function were analyzed. There were no significant differences in donor and recipient variables among the three groups. The frequencies of graft loss were 15 of 118 grafts (12.7%) in group A, 4 of 36 grafts (11.1%) in group B, and 9 of 27 grafts (33.3%; P <.05 v groups A and B) in group C. The liver enzyme values in groups B and C were significantly greater than those in group A postoperatively. The prothrombin times of group C were significantly longer than those of group A for the first 4 postoperative days. Recipients of hepatic allografts from donors with uncorrected hypernatremia had a significantly greater incidence of graft loss compared with recipients of hepatic allografts from normonatremic donors. However, the differences in graft survival were abrogated by the correction of donor hypernatremia before procurement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477844     DOI: 10.1002/lt.500050510

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  22 in total

Review 1.  Strategies to optimize the use of marginal donors in liver transplantation.

Authors:  Daniele Pezzati; Davide Ghinolfi; Paolo De Simone; Emanuele Balzano; Franco Filipponi
Journal:  World J Hepatol       Date:  2015-11-18

Review 2.  [Expanding the liver donor pool through extended-criteria donation].

Authors:  J Pratschke; J Mittler; P Neuhaus
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

3.  Increase in post-reperfusion sensitivity to tissue plasminogen activator-mediated fibrinolysis during liver transplantation is associated with abnormal metabolic changes and increased blood product utilisation.

Authors:  Hunter B Moore; Angelo D'Alessandro; Ernest E Moore; Matthew Wither; Peter J Lawson; Benjamin R Huebner; Kirk Hansen; Rashikh Choudhury; Trevor L Nydam
Journal:  Blood Transfus       Date:  2019-02-04       Impact factor: 3.443

Review 4.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

Review 5.  Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.

Authors:  Dronacharya Routh; Sudeep Naidu; Sanjay Sharma; Priya Ranjan; Rajesh Godara
Journal:  J Clin Exp Hepatol       Date:  2013-12-05

6.  Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants.

Authors:  Andrew M Cameron; R Mark Ghobrial; Hasan Yersiz; Douglas G Farmer; Gerald S Lipshutz; Sherilyn A Gordon; Michael Zimmerman; Johnny Hong; Thomas E Collins; Jeffery Gornbein; Farin Amersi; Michael Weaver; Carlos Cao; Tony Chen; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2006-06       Impact factor: 12.969

Review 7.  Glycemic control and organ transplantation.

Authors:  Michael R Marvin; Vicki Morton
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 8.  Critical care of the potential organ donor.

Authors:  Anna J Dare; Adam S Bartlett; John F Fraser
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 9.  The role of innate immunity in donor organ procurement.

Authors:  Dianne B McKay
Journal:  Semin Immunopathol       Date:  2011-03-23       Impact factor: 9.623

10.  Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential.

Authors:  Sam D Shemie; Heather Ross; Joe Pagliarello; Andrew J Baker; Paul D Greig; Tracy Brand; Sandra Cockfield; Shaf Keshavjee; Peter Nickerson; Vivek Rao; Cameron Guest; Kimberly Young; Christopher Doig
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.